Avivagen Inc V.VIV.H

Alternate Symbol(s): VIVXF

Healthcare

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

TSXV:VIV.H - Post by User

Avivagen Inc > Avivagen reports they sold 15 dog treats on Amazon

<< Previous

Bullboard Posts

Next >>

Comment by StoneMan45on Oct 06, 2020 2:16pm

74 Views

Post# 31674386

RE:RE:RE:Avivagen reports they sold 15 dog treats on Amazon

Won't need to try the dog chews as Kym stated that OxC beta for the human use market will be out on or before Black Friday, so November 26th 2020. The expectation that it should help in alleviating the severe effects of Covid (the overzealous inflamation response that seems to be the cause for most concern) as well as supporting the bodies own defenses against infection '..OxC-beta product supports and primes the innate immune system while also dampening chronic, overzealous inflammatory responses..'

should be a busy end to this year.

<< Previous

Bullboard Posts

Next >>

Mid-year update: Charting GameSquare’s sharp business growth